Facebook Twitter
Print

Including Health Economic Evaluations into Clinical Studies

14:00 - 17:00, Orchid C, Terrace Level

Claudia Witt (1), Patricia Herman (2)

 

(1): Institute for Social Medicine, Epidemiology, and Health Economics, Charité - Universitätsmedizin Berlin, Germany

(2): The Research and Development (RAND) Corporation, United States

 

Healthcare costs continue to grow and it is apparent that this growth is unsustainable. In this environment it important that decision makers have data not only on the safety, efficacy and effectiveness of healthcare alternatives, but also on their costs. Also, in the growing field of comparative effectiveness research decision makers are increasingly interested in cost information. In the absence of empirical data, many policy makers ignore the therapies used in integrative medicine because they are considered to be “add-ons”—i.e., they are believed to only increase overall healthcare costs. However, a recent review the cost effectiveness studies that have been performed indicate that at least some of these therapies may be cost saving. The overall goals of this workshop are threefold: 1) to introduce participants to economic evaluation and its uses; 2) to enable participants to better interpret the economic evaluation literature; and 3) to prepare those interested in performing an economic evaluation. This workshop will use a combination of lecture and individual and whole and small group exercises to give participants a strong foundation in economic evaluation in general, and the cost-effectiveness and cost-utility of integrative medicine specifically. Participants will also benefit from a list of resources offering additional information on the topics covered.